|
News FDA Drug Safety Communication: Update: Preliminary findings from ongoing investigations of CardioGen-82
The U.S. Food and Drug Administration (FDA) is updating healthcare professionals and the public about preliminary findings from ongoing investigations following the voluntary recall of CardioGen-82 on July 25, 2011 |
|
News FDA Drug Safety Communication: Increased radiation exposure due to undetected strontium breakthrough when using CardioGen-82 for cardiac positron emission tomography (PET) scans
The U.S. Food and Drug Administration (FDA) is alerting the public; in particular, the medical imaging community; about the potential for inadvertent, increased radiation exposure in patients who underwent or will be undergoing cardiac positron emission tomography (PET) scans with rubidium (Rb)-82 chloride injection from CardioGen-82 (manufactured by Bracco Diagnostics, Inc.). |
|
News FDA working to prevent radiation overdoses during CT scans
The U.S. Food and Drug Administration has been investigating reports that patients undergoing computed tomography (CT) brain perfusion scans were accidently exposed to excess radiation. |
|
Article Radiation Exposure
Radiation is energy that travels in the form of waves or high-speed particles. It occurs naturally in sunlight and sound waves. |
|
Article Radiation Therapy Oncology Group
For 40 years, the Radiation Therapy Oncology Group (RTOG) has been a recognized leader in working to increase survival and improve the quality of life for cancer patients. |
|
Article Underbrush
Hippophae rhamnoidas - the ashen underbrush, the river underbrush. |
